6.49
Scilex Holding Company stock is traded at $6.49, with a volume of 32,334.
It is down -4.59% in the last 24 hours and down -23.58% over the past month.
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
See More
Previous Close:
$6.76
Open:
$6.52
24h Volume:
32,334
Relative Volume:
0.27
Market Cap:
$45.22M
Revenue:
$33.86M
Net Income/Loss:
$-437.38M
P/E Ratio:
-0.1599
EPS:
-40.5773
Net Cash Flow:
$-42.07M
1W Performance:
-3.59%
1M Performance:
-23.58%
6M Performance:
-20.07%
1Y Performance:
-64.33%
Scilex Holding Company Stock (SCLX) Company Profile
Name
Scilex Holding Company
Sector
Industry
Phone
(650) 516-4310
Address
960 SAN ANTONIO ROAD, PALO ALTO
Compare SCLX vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SCLX
Scilex Holding Company
|
6.43 | 47.54M | 33.86M | -437.38M | -42.07M | -40.58 |
|
LLY
Lilly Eli Co
|
1,188.14 | 1.05T | 72.25B | 25.28B | 10.37B | 27.78 |
|
JNJ
Johnson Johnson
|
261.58 | 627.42B | 97.93B | 21.04B | 17.80B | 8.6278 |
|
ABBV
Abbvie Inc
|
250.23 | 440.83B | 62.82B | 3.60B | 19.98B | 2.0274 |
|
MRK
Merck Co Inc
|
135.69 | 335.14B | 65.51B | 8.93B | 14.12B | 3.5532 |
|
NVS
Novartis Ag Adr
|
151.95 | 286.78B | 54.66B | 13.58B | 16.05B | 7.0171 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-25 | Initiated | D. Boral Capital | Buy |
| Oct-16-24 | Initiated | Alliance Global Partners | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-16-23 | Initiated | B. Riley Securities | Buy |
| Oct-13-23 | Initiated | B. Riley Securities | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
View All
Scilex Holding Company Stock (SCLX) Latest News
JP 3E Holdings appoints three directors to board By Investing.com - Investing.com Australia
Scilex Completes Vivasor Acquisition, Reports Q2 Net Loss of $42.1M - Minichart
Scilex Holding Co Q2 2026: Revenue $7.6M, Net loss $(114.7M), EPS $(16.65) — 10-Q Summary - TradingView
Scilex Holding Company (SCLX) flags going concern risk after $158M loss - Stock Titan
Scilex Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
JP 3E Holdings Adds Three Directors as Strategic Metals Initiatives Advance - citybiz
JP 3E Holdings, Inc. Appoints Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to Board of Directors - The Manila Times
Scilex Establishes $20 Million Credit Facility for Vivasor - The Globe and Mail
Scilex Holding establishes $20 million revolving credit line for Vivasor - Investing.com
Form 8K Scilex Holding Co For: 12 August By Investing.com - Investing.com Canada
Scilex Holding CoEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8 - TradingView
Scilex Holding establishes $20 million revolving credit line for Vivasor By Investing.com - Investing.com Canada
Scilex Establishes Uncommitted $20 Million 10-Year Revolving Line of Credit for Vivasor - TradingView
Scilex Holding Co (SCLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scilex Holding Company Revenue Breakdown – BOATS:SCLXW - TradingView
Scilex Holding (SCLX) Slips 1.58% to $6.56 as Key Support at $6.23 Moves into FocusComposite Profile - dars.gov.et
Scilex (NASDAQ:SCLX) Trading 0.9% HigherShould You Buy? - MarketBeat
Scilex Holding Company Revenue Breakdown – NASDAQ:SCLX - TradingView
Scilex Holding (SCLX) Edges Lower to $6.55 as Traders Eye Key Support at $6.22Sentiment Extreme - dars.gov.et
SCLX|Scilex Holding Co|Price:7.100|Chg%:+0.260 - TradingKey
Scilex Holding Co (SCLX) Institutional Confidence - TradingKey
Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scilex Holding Co (SCLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SCLX|Scilex Holding Co|Price:6.870|Chg%:+0.030 - TradingKey
SCLX|Scilex Holding Co|Price:6.610|Chg%:-0.055 - TradingKey
Scilex Holding Co (SCLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Scilex Holding Co (SCLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scilex Holding Co (SCLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCLX|Scilex Holding Co|Price:6.950|Chg%:+0.010 - TradingKey
Scilex Holding Co (SCLX) Cash Flow - TradingKey
Scilex Holding Co (SCLX) Income Statement - TradingKey
Scilex Holding Company Revenue Breakdown – NASDAQ:SCLXW - TradingView
Scilex Holding Company Revenue Breakdown – DUS:D8B0 - TradingView
Scilex Holding (SCLX) Declines Sharply as Selling Pressure MountsVolume Profile - dars.gov.et
Scilex Holding (SCLX) Dips 3.9% as Key Support Levels Come into FocusSmart Money Flow Stocks - dars.gov.et
Scilex Announces Strategic Sale of Vivasor Preferred Shares - The Globe and Mail
Scilex Holding Company Enters Material Definitive Agreement – SEC Filing and Entity Information Details - Minichart
Scilex Sells Vivasor Preferred Shares Back for $12.0 Million, Paid in Tranches Through 2027 - TradingView
Scilex Holding (SCLX) Declines 5.33% as Shares Test Key Support Near $7.59High Conviction Picks - dars.gov.et
Scilex Holding Company (SCLX) Edges Lower, Holds Near Critical Support LevelNews Sentiment - dars.gov.et
SCLX Q1 2026 Earnings: Net Loss of $4.76 Per Share, Stock Rises 5.25% Despite No RevenuePeak Earnings Alert - po-news-eg.net
Enterprise value to revenue forward of Scilex Holding Company – DUS:D8B0 - TradingView
Scilex Holding (SCLX) Surges 5.25%: Testing Key Resistance at $9.68RTH Profile - dars.gov.et
Scilex Holding(SCLX) Stock Options Chain | Quotes & News - Moomoo
Scilex Holding Company Warrant (SCLXW) Declines Sharply, Testing Key Support at $0.18Sweep Order Flow - dars.gov.et
Price to earnings forward of Scilex Holding Company – NASDAQ:SCLX - TradingView
Price to sales forward of Scilex Holding Company – NASDAQ:SCLX - TradingView
Scilex (NASDAQ:SCLX) Trading Up 0.8%Here's What Happened - MarketBeat
Form 13D/A Scilex Holding Company For: 7 July By Investing.com - Investing.com UK
Form 4 Scilex Holding Co For: 7 July By Investing.com - Investing.com India
Scilex Holding Company Stock (SCLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scilex Holding Company Stock (SCLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | 10% Owner |
Jan 14 '26 |
Sale |
0.72 |
5,115,586 |
3,683,733 |
213,766,229 |
| Scilex Holding Co | 10% Owner |
Jan 13 '26 |
Sale |
0.91 |
175,139 |
159,674 |
218,881,815 |
| Scilex Holding Co | 10% Owner |
Jan 06 '26 |
Sale |
1.37 |
6,053,708 |
8,282,078 |
238,391,552 |
| Scilex Holding Co | 10% Owner |
Jan 07 '26 |
Sale |
1.20 |
4,835,581 |
5,808,983 |
233,555,971 |
| Scilex Holding Co | 10% Owner |
Jan 08 '26 |
Sale |
1.07 |
3,824,201 |
4,085,394 |
229,731,770 |
| Scilex Holding Co | 10% Owner |
Dec 30 '25 |
Sale |
0.54 |
9,657,300 |
5,209,148 |
244,445,260 |
| Scilex Holding Co | 10% Owner |
Dec 29 '25 |
Sale |
0.66 |
7,310,984 |
4,792,350 |
254,102,560 |
| Scilex Holding Co | 10% Owner |
Dec 26 '25 |
Sale |
0.75 |
3,689,016 |
2,770,082 |
261,413,544 |
| Scilex Holding Co | 10% Owner |
Nov 28 '25 |
Sale |
2.06 |
422,299 |
871,161 |
265,102,560 |
| Scilex Holding Co | 10% Owner |
Sep 23 '25 |
Sale |
16.00 |
11,945,151 |
191,122,416 |
181,804,849 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):